The U.S. Food and Drug Administration today approved Adempas (riociguat) to treat adults with two forms of pulmonary hypertension. Pulmonary hypertension is caused by abnormally high blood pressure in the arteries of the lungs.
Med-Chemist : "Quintessential Medicinal Chemistry"
Friday, October 18, 2013
Adempas drug gets FDA approval for treatment of pulmonary hypertension
No comments:
Post a Comment